The Princess Margaret, with its world-leading research facility, the Ontario Cancer Institute (OCI), is especially well-suited to excel and succeed in developing new drugs for cancer patients.  That is because the facility is: focused 100 percent on cancer research and treatment, including all types of cancer

• a world leader in basic science research, and
• located in a large, multicultural city which provides a large patient base for clinical studies

This article provides background information on the steps involved in developing a new cancer drug and bringing it to market, followed by descriptions of specific drug development initiatives going on at The Princess Margaret.
»More

Videos:
Dr. Lillian Siu, Co-Director of the Robert and Maggie Bras Drug Development Program, speaks about some of the successes and her aspirations.
Dr. Aaron Schimmer, a Scientist with OCI’s Division of Cancer Genomics and Proteomics and one of the Report on Business Top 40 Under 40 talks about some promising drug developments at The Princess Margaret